top of page
Executive Spotlights

Synchron Raises $75M Series C Led by ARCH Venture Partners to Advance Endovascular Brain-Computer

New York, NY, December 15, 2022 (Business Wire) -- Synchron, the endovascular brain-computer interface (BCI) company, announced today an oversubscribed $75 million Series C financing round led by ARCH Venture Partners. Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors. Existing investors, including Khosla Ventures, NeuroTechnology Investors, METIS, Forepont Capital Partners, ID8 Investments, Shanda Group and University of Melbourne participated in the round. The Series C funding brings the total amount raised since inception to $145 million.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page